A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)

Patients with metastatic renal cell cancer (mRCC) for whom surgery is ineffective may experience a poor prognosis. The different sites where cancer has spread, and the different ways to treat it in the immune checkpoint inhibitors era could help clinical decision-making. In this study, individuals w...

Descripción completa

Detalles Bibliográficos
Autores principales: Alradhi, Mohammed, Zhang, Zewen, Safi, Mohammed, Al-danakh, Abdullah, Aldhbi, Mokhtar, Baldi, Salim, kui, Li, Alradhi, Abdulaziz, Hamri, Saeed Bin, Lun lo, Ka, Zhao, Yi, Jin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846485/
https://www.ncbi.nlm.nih.gov/pubmed/36686665
http://dx.doi.org/10.3389/fphar.2022.996404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846485/
https://www.ncbi.nlm.nih.gov/pubmed/36686665
http://dx.doi.org/10.3389/fphar.2022.996404

Ejemplares similares